PubMed HealthSearch

PubMed · 7572293

Spider bites.

Abstract

BACKGROUND: This review provides the physician with a clinical approach to the diagnosis and management of spider bites. It examines the recent literature concerning management of bites causing dermonecrosis, secondary infection, neuromuscular damage, and allergic reactions. METHODS: Using the key words "spider bites," "brown recluse spider bites," "necrotic arachnidism," "black widow spider bites," "latrodectism," and "Tegenaria agrestis (Hobo spider)," the MEDLINE files were researched for articles pertinent to the practicing physician. Texts related to spiders and spider bites were also consulted. RESULTS AND CONCLUSIONS: At least 60 species of spiders have been implicated in human bites. Most cause bites of minimal medical importance, requiring little treatment. Some (brown recluse, Hobo spider) cause severe cutaneous and systemic reactions requiring intensive medical management. The black widow bite can cause severe neurologic problems requiring the use of antivenin. Spider bites are frequently difficult to diagnose because the spider is not seen at the time of the suspected bite. Such bites should be labeled arthropod bites, vector unknown.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J R Blackman. Spider bites.. https://pubmed.ncbi.nlm.nih.gov/7572293/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.

In order to study the role of gyrB in antibiotic resistance in post-ciprofloxacin therapy fluoroquinolone-resistant clinical isolates of Salmonella typhimurium, plasmid pBP548, which contains the Escherichia coli gyrB gene, was used in complementation studies. In a heterodiploid strain, the wild-type (quinolone sensitive) allele is dominant over the resistant allele therefore, eleven clinical isolates were complemented with gyrB encoded on pBP548. Only one transformant, L18pBP548, exhibited increased susceptibility to the quinolones nalidixic acid, ciprofloxacin and sparfloxacin. The amino acid sequence of the gyrase B protein from a wild-type and the pre-therapy S. typhimurium (deduced from the nucleotide sequence) was identical to that of E. coli from codons 436 to 470; however, a point mutation was identified in codon 463 of gyrB of the quinolone-resistant post-therapy isolate L18, giving rise to an amino acid substitution of serine to tyrosine.

Anti-Infective Agents